Table 2 Individual data for chickens in primary exposure study
Bird Identification | Inoculum | Route of exposure | Sex | Survival time (days) | Experimental outcome (E/D)aand occurrence of syndromes (M/N)b |
|---|---|---|---|---|---|
986 | Bovine BSE | Parenteralc | f | 65 | (E) Neurological signs, NSL |
988 | Bovine BSE | Parenteral | f | 273 | (D)/NSL |
982 | Bovine BSE | Parenteral | m | 274 | (D)/NSL |
981 | Bovine BSE | Parenteral | f | 378 | (E) Egg peritonitis |
983d | Bovine BSE | Parenteral | m | 664 | (E) Acute onset (M) |
980d | Bovine BSE | Parenteral | m | 1302 | (D)/NSL (M/N) |
984d | Bovine BSE | Parenteral | m | 1486 | (D)/NSL (M) |
989 | Bovine BSE | Parenteral | f | 1780 | (D) Ovarian adenocarcinoma (N) |
979 | Bovine BSE | Parenteral | f | 1804 | (E) Ovarian adenocarcinoma (N) |
987 | Bovine BSE | Parenteral | f | 1841 | Terminal kill/NSL (M/N) |
985§ | Bovine BSE | Parenteral | m | 1841 | Terminal kill/NSL (M/N) |
990 | Bovine BSE | Parenteral | f | 1843 | Terminal kill/NSL (M/N) |
966 | Bovine BSE | Oral | f | 390 | (E) Hepatitis |
970 | Bovine BSE | Oral | f | 573 | (E) Weight loss |
976d | Bovine BSE | Oral | m | 1230 | (E) (M) |
978d | Bovine BSE | Oral | m | 1413 | (E) (M) |
969d | Bovine BSE | Oral | m | 1555 | (E) Collapse (M) |
965d | Bovine BSE | Oral | m | 1601 | (E) (M) |
967 | Bovine BSE | Oral | f | 1808 | (D) Ovarian adenocarcinoma |
971 | Bovine BSE | Oral | f | 1830 | Terminal kill/NSL (N) |
968 | Bovine BSE | Oral | f | 1830 | Terminal kill/NSL (N) |
977 | Bovine BSE | Oral | m | 1834 | Terminal kill/NSL (M) |
972 | Bovine BSE | Oral | f | 1834 | Terminal kill/NSL (N) |
959 | Saline | Parenteral | f | 222 | (D) |
958 | Saline | Parenteral | m | 395 | (E) Weight loss |
955 | Saline | Parenteral | m | 757 | (D) |
960 | Saline | Parenteral | m | 862 | (E) Weight loss/NSL |
956 | Saline | Parenteral | m | 1037 | (D)/NSL |
964 | Saline | Parenteral | m | 1037 | (E) Neurological signs/NSL |
951 | Saline | Parenteral | m | 1225 | (E) Neurological signs/NSL |
961 | Saline | Parenteral | f | 1310 | (E) Egg peritonitis |
954 | Saline | Parenteral | f | 1528 | (E) Weight loss/NSL |
963 | Saline | Parenteral | f | 1547 | (D) Ovarian adenocarcinoma (N) |
953b | Saline | Parenteral | m | 1837 | (D) Meningoencephalitis (N) |
952b | Saline | Parenteral | f | 1868 | Terminal kill/NSL |
962b | Saline | Parenteral | f | 1868 | Terminal kill/NSL (N) |
957b | Saline | Parenteral | f | 1868 | Terminal kill/splenomegaly/meningo-encephalitis (N) |